共 50 条
- [43] Serum sclerostin and adverse outcomes in elderly patients with stable coronary artery disease undergoing percutaneous coronary intervention [J]. Aging Clinical and Experimental Research, 2020, 32 : 2065 - 2072
- [46] Impact of Nonalcoholic Fatty Liver Disease on Myocardial Perfusion in Nondiabetic Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (12): : 1810 - 1814